Status:

COMPLETED

Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia

Lead Sponsor:

Medtronic Cardiac Ablation Solutions

Conditions:

AtrioVentricular Nodal Reentrant Tachycardia

Supraventricular Tachycardia

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

ICY-AVNRT (Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia) is a prospective multi-center, nonrandomized, single arm, controlled, unblinded, investigational clinical study. ...

Eligibility Criteria

Inclusion

  • Pre-Electrophysiology Study
  • Supraventricular tachycardia (SVT) compatible with atrioventricular nodal reentrant tachycardia (AVNRT), documented by ECG, TTM, Holter or event monitor
  • Pre-Electrophysiology Study

Exclusion

  • History of sustained (≥30 seconds) of ventricular tachycardia
  • Atrial tachycardia or other arrhythmia that could be confused with AVNRT
  • Reversible cause of SVT
  • History of previous AVNRT ablation
  • Therapy with amiodarone within last 90 days
  • Unstable angina/myocardial infarction/open heart surgery in past 60 days
  • New York Heart Association (NYHA) Classification III or IV currently or within the past 90 days
  • Implantable cardiac rhythm device
  • Atrioventricular block (first degree (PR interval ≥ 220ms), second degree, or third degree) or left bundle branch block
  • Stroke or transient ischemic attack within the past 180 days
  • Life expectancy less than 12 months
  • Female known to be pregnant
  • Unable/unwilling to give informed consent
  • Unable/unwilling to comply with follow-up visits and study requirements
  • Less than 18 years of age
  • Active systemic infection
  • Cryoglobulinemia
  • Other conditions where the manipulation of the catheter would be unsafe (for example, intracardiac mural thrombus)
  • Participating in a concurrent clinical study that may confound the results of this study
  • Post-Electrophysiology Study Inclusion Criteria:
  • Subject must have one electrophysiology study documented inducible sustained (greater than or equal to 15 seconds) supraventricular tachycardia that is classified as AVNRT.
  • Post-Electrophysiology Study

Key Trial Info

Start Date :

May 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2016

Estimated Enrollment :

572 Patients enrolled

Trial Details

Trial ID

NCT01426425

Start Date

May 1 2012

End Date

September 1 2016

Last Update

February 13 2025

Active Locations (34)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (34 locations)

1

Banner Good Samaritan Medical Center

Phoenix, Arizona, United States, 85006

2

Pacific Heart Institute

Santa Monica, California, United States, 90404

3

Stanford Hospital and Clinics

Stanford, California, United States, 94305

4

Baptist Hospital of Miami

Miami, Florida, United States, 33176